Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Stelazine 1mg/5ml syrup
0402010X0BBAFAF
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
|
Stelazine 2mg Spansules
0402010X0BBACAA
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
|
Stelazine 5mg tablets (Imported)
0402010X0BBALAI
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
|
Stelazine 5mg tablets (Mercury Pharma)
0402010X0BBABAI
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
|
Stelazine Forte 1mg/ml oral solution
0402010X0BBAJAK
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
|
Stemetil 25mg suppositories
0406000T0BBAFAF
|
Stemetil (Suppositories/Tablet) | Prochlorperazine maleate | Central Nervous System | No data available |
|
Stemetil 5mg suppositories
0406000T0BBAEAE
|
Stemetil (Suppositories/Tablet) | Prochlorperazine maleate | Central Nervous System | No data available |
|
Stemetil Eff 5mg sachets
0406000U0BBADAD
|
Stemetil (Injection/Sachet/Syrup) | Prochlorperazine mesilate | Central Nervous System | No data available |
|
Strawberry Pain Relief 3 Months Plus Paracetamol 120mg/5ml
0407010H0B3AGAW
|
Boots Pain Relief (Paracetamol) | Paracetamol | Central Nervous System | No data available |
|
Suboxone 16mg/4mg sublingual tablets
0410030B0BBACAC
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Sudafed Blocked Nose & Headache capsules
0407010X0CYACAF
|
Sudafed (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | No data available |
|
Sudafed Day & Night capsules
0407010X0CYAAA0
|
Sudafed (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | No data available |
|
Sudafed Mucus Relief Day & Night capsules
0407010X0CYAEA0
|
Sudafed (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | No data available |
|
Sudafed Non-Drowsy Dual Relief capsules
0407010X0CBAAAF
|
Sudafed Dual Relief | Paracetamol combined preparations | Central Nervous System | No data available |
|
Sulpiride 100mg/5ml oral liquid
0402010U0AAAPAP
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 10mg/5ml oral liquid
0402010U0AAAZAZ
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 150mg/5ml oral liquid
0402010U0AAAUAU
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 200mg/5ml oral liquid
0402010U0AAANAN
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 250mg/5ml oral liquid
0402010U0AAAVAV
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 25mg/5ml oral liquid
0402010U0AAATAT
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 300mg/5ml oral liquid
0402010U0AAARAR
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 400mg/5ml oral liquid
0402010U0AAASAS
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 500mg/5ml oral liquid
0402010U0AAAYAY
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 50mg/5ml oral liquid
0402010U0AAAMAM
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
|
Sulpiride 70mg/5ml oral liquid
0402010U0AAAWAW
|
Sulpiride | Sulpiride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.